ESC 365 - CCMHFpEF: Is CCM Therapy safe and effective in patients with HFpEF?

HFA Premium Access

CCMHFpEF: Is CCM Therapy safe and effective in patients with HFpEF?

Session: Late-Breaking Clinical Trial - Devices

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Professor C. Linde (Stockholm, SE)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Professor Cecilia Marianne Linde

Karolinska Institute, Stockholm (Sweden)

65 presentations

6 followers

3 more presentations in this session

ENDO-HF Neuromodulation in Heart Failure

Speaker: Professor A. Stewart Coats (Sydney, AU)

REBALANCE-HF Roll In Cohort

Speaker: Doctor M. Fudim (Durham, US)

GHIDD - Glycemic variability and hyperglycemia in HFpEF

Speaker: Professor G. Fazio (Palermo, IT)

Access the full session

Late-Breaking Clinical Trial - Devices

Speakers: Professor C. Linde, Professor A. Stewart Coats, Doctor M. Fudim, Professor G. Fazio

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources